NovoCure Limited

(NVCR) Trade

By |

Profile

NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.

Contact Information

Website: www.novocure.com
Email: investorinfo@novocure.com
Main Phone: +44 1534756700
Address: Grenville Street
Address 2: No. 4 The Forum
City / Town: St. Helier
Country: JEY
Postal Code: JE2 4UF

Issuer Information

Exchange: NGS
CEO: Asaf Danziger
Employees: 495
NAICS: Surgical and Medical Instrument Manufacturing(339112)
$ 48.65 $ -0.55 (-1.12%)
Last Price 48.65 Change $ -0.55 Change % -1.12 Tick N/A
Bid 48.00 Bid Size 700.00 Ask 49.00 Ask Size 300.00
Open 49.20 High 49.95 Low 48.55 Prev Close 49.20
Last Trade Volume 976,679 52 Wk Hi 52.35 52 Wk Low 16.10
Market Cap 4.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 92,902,560.00 EPS (TTM) -0.66 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 96 184
Number of Buys 31 54
Number of Sells 65 130
Net Activity 422921 -178823
Last 10 Buys Shares
Gert Lennart Perlhagen 1,000
Robert J. Mylod 1,000
Asaf Danziger 1,000
Last 10 Sell Shares
Eilon Kirson 1,000
Eilon Kirson 1,000
Eilon Kirson 1,000
Eilon Kirson 1,000
Asaf Danziger 1,000
Asaf Danziger 1,000
Asaf Danziger 1,000
Asaf Danziger 1,000
Asaf Danziger 1,000
Charles G. Phillips 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 33 33 33 33
Low Target Price Estimate 30 30 30 30
Mean Target Price Estimate 31.8 31.8 31.8 31.8
Standard Deviation 1.3 1.3 1.3 1.3
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 05/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 4 4
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1.4 1.4